Nishant Agrawal to Carcinoma, Transitional Cell
This is a "connection" page, showing publications Nishant Agrawal has written about Carcinoma, Transitional Cell.
Connection Strength
0.183
-
Association of artificial intelligence-powered and manual quantification of programmed death-ligand 1 (PD-L1) expression with outcomes in patients treated with nivolumab ± ipilimumab. Mod Pathol. 2022 11; 35(11):1529-1539.
Score: 0.183